Clinical Trial Update: Safety Study of Intranasal Insulin in Type 1 Diabetes and Diabetic Peripheral Neuropathy [Phase 2]

View source ↗

Summary

A completed Phase 2 safety study evaluating intranasal insulin for diabetic peripheral neuropathy in individuals with Type 1 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy
• Type 1 Diabetes Mellitus

Drugs mentioned

• Intranasal insulin (insulin)

Snippet

Sponsor: University of Calgary | Conditions: Diabetic Peripheral Neuropathy | Phase 2 | Status: COMPLETED